Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections – Pipeline Review, H2 2016


Posted January 4, 2017 by Shirley

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections – Pipeline Review, H2 2016 is a professional and in-depth study.
 
MRRS adds "Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections – Pipeline Review, H2 2016" latest studies, published in December 2016. It is a professional and in-depth study.

Summary
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections – Pipeline Review, H2 2016, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) pipeline landscape.

Vancomycin resistant staphylococcus infection is a condition caused by bacteria (germs). This infection occurs when bacteria, called Staphylococcus aureus or Staph, becomes resistant (not killed) to the antibiotic medicine vancomycin. Risk factors include taking strong antibiotics the wrong way may cause the bacteria to develop resistance to the antibiotics, weak immune system and staying in the hospital too long. Symptoms include fever, chills, cough, chest pain, trouble breathing, and a fast heartbeat.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease).
– The pipeline guide reviews pipeline therapeutics for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease)

Table Of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Overview 6
Therapeutics Development 7
Pipeline Products for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Overview 7
Pipeline Products for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Comparative Analysis 8
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Therapeutics under Development by Companies 9
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Therapeutics under Investigation by Universities/Institutes 10
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Products under Development by Companies 13
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Products under Investigation by Universities/Institutes 14
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Companies Involved in Therapeutics Development 15
CrystalGenomics Inc 15
Debiopharm International SA 16
e-Therapeutics Plc 17
iNtRON Biotechnology Inc 18
Wockhardt Ltd 19
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
....

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/vancomycin-resistant-staphylococcus-aureus-vrsa-infections-pipeline-review-h2-2016

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Marketing , Reports
Last Updated January 4, 2017